GIBRALTAR, June 08, 2026 (GLOBE NEWSWIRE) -- ADI Predictstreet, the new global prediction market platform, today announced its official launch, marking a major milestone in the evolution of how soccer fans engage with the sport.

LONDON, June 08, 2026 (GLOBE NEWSWIRE) -- Black Castle Capital Partners today announced a defining moment for grassroots sport as Kabuni Sports unveiled its AI-powered sports ecosystem at a landmark showcase in Mumbai,

SCOTTSDALE, Ariz., June 08, 2026 (GLOBE NEWSWIRE) -- Summary The onsemi Elite Pairing Studio is an online design environment that simplifies pairing SiC MOSFETs and gate drivers for demanding power electronics applications, including AI data centers, e

Nanterre, June 08, 2026 (GLOBE NEWSWIRE) -- Nanterre, June 8, 2026 - North Atlantic France recalls that, on November 28, 2025, it announced the successful closing of its acquisition of 82.89% of the share capital and voting rights of Esso S.A.F, renam

SINGAPORE - Media OutReach Newswire - 8 June 2026 - The Singapore International Water Week (SIWW) 2026 will bring together thought leaders, experts and practitioners from governments, cities,

COPENHAGEN, Denmark and EDINBURGH, Scotland, June 08, 2026 (GLOBE NEWSWIRE) -- Copenhagen Infrastructure Partners (CIP), on behalf of Copenhagen Infrastructure IV (CI IV), has agreed to divest minority stakes in the Devilla battery storage project

KUALA LUMPUR, Malaysia, June 08, 2026 (GLOBE NEWSWIRE) -- Digital Realty (NYSE: DLR), the world's largest cloud- and carrier-neutral data center platform, today announced the establishment of its Malaysia platform

HONG KONG SAR - Media OutReach Newswire - 8 June 2026 - Simon Chan, Chairman of Cyberport, joined the business delegation led by Chief Executive John Lee, on a visit to Kazakhstan and Uzbekistan from 1 to 5 June 2026 to strengthen innovation technology (I

SINGAPORE - Media OutReach Newswire - 8 June 2026 - Trransfer Technologies, a global B2B ground transportation platform serving corporate travel managers, private aviation firms

Ingelheim, Germany - Boehringer Ingelheim today announced positive results from two global Phase III trials of its glucagon/GLP-1 dual agonist survodutide (BI 456906), SYNCHRONIZE-1 and SYNCHRONIZE-MASLD.2,4 The results demonstrate survodutide's